<DOC>
	<DOCNO>NCT02958150</DOCNO>
	<brief_summary>This study compare effectiveness dexmedetomidine sedative drug NIV different strategy routinely use patient ARF different aetiology . Efficacy assess base absence intubation , short term prognosis , occurrence medical complication .</brief_summary>
	<brief_title>Dexmedetomidine Versus Standard Clinical Practice During Non Invasive Mechanical Ventilation</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Patients 18 year age . Competent legal representative able sign inform consent . Reversible ARF secondary heart failure , COPD exacerbation , pneumonia , risk potextubation failure* meet criterion start NIV . Signs symptoms respiratory distress Moderate severe dyspnoea , grater usual and/or Respiratory rate great 25 COPD great 30 hypoxemic ARF and/or Use accessory muscle and/or paradoxical breathe and/or Hypercapnic encephalopathy And change gas exchange PaCO2 &gt; 45 mmHg , pH &lt; 7.35 and/or PaO2/FiO2 300 150 . *Patients risk postextubation failure : Patients meet least one follow criterion . Impaired consciousness . Age 65 year Heart failure EF &gt; 30 % Severe disease Acute Physiology Chronic Health Evaluation ( APSCHE ) score &gt; 12 . Protracted wean extubation Respiratory arrest , direct indication OTI IMV . Severe unstable comorbidity ( myocardial ischemia ejection fraction &lt; 30 % , arrythmia , uncontrolled hypotension define systolic blood pressure le 90 mmHg dos norepinephrine &gt; 0.5 mcg/kg/min and/or dobutamine &gt; 10 mcg/kg/min ) . Inability protect airway : bronchial aspiration . Fixed upper airway obstruction . Tracheostomy . Undrained pneumothorax . Severe agitation lack collaboration patient despite medication administer . Facial burn trauma . Facial surgery anatomical change prevent mask fitting . Hypersensitivity active substance excipients list section 6.1 . Allergy egg , soya , peanut . HR &lt; 50 bpm induce beta blocker . Advanced heart block ( grade 2 3 ) unless pace . Acute cerebrovascular condition . Increased intracranial pressure . Closed angle glaucoma . Myasthenia gravis . Concurrent use CYP3A4 inhibitor ( amprenavir , atazanavir , ritonavir ) . Refuse participate trial . Pregnant nursing patient .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>